ライフサイエンスコーパス: tobacco smoking

1 ically involved in the reinforcing effect of tobacco smoking.

2 models adjusted for age, sex, and cumulative tobacco smoking.

3 increased with each additional pack-year of tobacco smoking.

4 Risk factors for periodontal disease include tobacco smoking.

5 r levels by 6 to 12 weeks of abstinence from tobacco smoking.

6 xplore the mutational burden associated with tobacco smoking.

7 is a major cause for starting or increasing tobacco smoking.

8 ntribute to the perpetuation of addiction to tobacco smoking.

9 on between the level of fasting glycemia and tobacco smoking.

10 ich despite some success have not eliminated tobacco smoking.

11 use of death, and almost all of it is due to tobacco smoking.

12 the youngest infants and in those exposed to tobacco smoking.

13 exposure of the upper aerodigestive tract to tobacco smoking.

14 on with the effect of nonsmoking and regular tobacco smoking.

15 ion treatments and reduce the harm caused by tobacco smoking.

16 association with risk for IBD is modified by tobacco smoking.

17 t disease, diseases strongly associated with tobacco smoking.

18 , but this does not seem to be made worse by tobacco smoking.

19 ical tumors and that LOY could be induced by tobacco smoking.

20 e, the principal addictive component driving tobacco smoking.

21 geting prevention and cessation of waterpipe tobacco smoking.

22 ntified strong epigenetic signals related to tobacco smoking.

23 x disease, Barrett's esophagus, obesity, and tobacco smoking.

24 hrenia is associated with very high rates of tobacco smoking.

25 , for example, the "pack-years" variable for tobacco smoking.

26 diseases, respectively, were attributable to tobacco smoking.

27 (beta +/- SE 0.07 +/- 0.01; P < 0.0001) and tobacco smoking (0.64 +/- 0.26; P = 0.016), as well as w

28 risk ratio [RR] 1.41 [95% CI 1.26-1.57]) and tobacco smoking (1.46 [1.30-1.65]) than in HIV-negative

29 use (RR 1.36 [95% CI 1.10-1.69]; p=0.0050), tobacco smoking (1.90 [1.38-2.62]; p<0.0001), and smokel

30 positive women was 1.3% (95% CI 0.8-1.9) for tobacco smoking, 2.1% (1.1-3.4) for smokeless tobacco us

31 Tobacco smoking (3.806, one degree of freedom; P < .015,

32 ositive men was 24.4% (95% CI 21.1-27.8) for tobacco smoking, 3.4% (1.8-5.6) for smokeless tobacco us

33 In 2004, active tobacco smoking accounted for approximately 15.8% (95% C

34 Although tobacco smoking accounts for the majority of lung cancer

35 e no significant differences in gender, age, tobacco smoking, Acute Physiology and Chronic Health Eva

36 st associations, with the exception of daily tobacco smoking (adjusted OR 1.74, 95% CI 1.08-2.81), an

37 rders in general), including breast-feeding, tobacco smoking, alcohol consumption, and exposure to do

38 extensive questionnaire containing items on tobacco smoking, alcohol consumption, and occupational e

39 sion models that were adjusted for age, sex, tobacco smoking, alcohol drinking, and hypertension.

40 terms for age, sex, study center, education, tobacco smoking, alcohol drinking, hepatitis B surface a

41 Heavier tobacco smoking among people with schizophrenia (SCZ) ha

42 from the general population, in relation to tobacco smoking, an exposure with well-characterised hea

43 o specific risk factors, such as alcohol and tobacco (smoking and smokeless), but dietary factors and

44 ted with the widely accepted risk factors of tobacco smoking and alcohol use and is the end result of

45 mokers to assess whether baseline water pipe tobacco smoking and baseline snus use were associated wi

46 models to assess whether baseline water pipe tobacco smoking and baseline snus use were associated wi

47 or numerous potential confounders, including tobacco smoking and C-reactive protein levels.

48 Both tobacco smoking and circulating cardiac troponin I (cTnI

49 population density areas, and pack-years of tobacco smoking and decreases in subjects with history o

50 We studied the association between tobacco smoking and epigenome-wide methylation in non-tu

51 Tobacco smoking and female sex were associated with high

52 the documentation of an association between tobacco smoking and lung cancer.

53 anged by at least 2 percentage points (e.g., tobacco smoking and mental health conditions) were assoc

54 s to investigate the differential effects of tobacco smoking and nicotine on changes in GABAA recepto

55 We investigated whether tobacco smoking and other factors increase risk for Barr

56 and 95% confidence intervals, adjusting for tobacco smoking and other potential confounders.

57 childhood behavior might reduce early onset tobacco smoking and risk of tobacco dependence among smo

58 Tobacco smoking and smoke exposure during pregnancy and

59 emographic risk factors, baseline water pipe tobacco smoking and snus use were independently associat

60 Water pipe tobacco smoking and the use of snus at baseline.

61 Water pipe tobacco smoking and the use of snus independently predic

62 HIV-infected men ages 40-60, independent of tobacco smoking and traditional risk factors.

63 Clinician type, tobacco smoking, and age may be important clinical facto

64 , age, height, weight, total caloric intake, tobacco smoking, and education.

65 rhosis, diabetes, obesity, alcohol drinking, tobacco smoking, and host genetic polymorphisms.

66 had higher body mass index, a higher rate of tobacco smoking, and lower lung function.

67 obiome were observed with poor oral hygiene, tobacco smoking, and oral cancer.

68 for recurrent reflux, body mass index (BMI), tobacco smoking, and type of antireflux surgery.

69 Life-course persistent asthma and tobacco smoking are risk factors for irreversible airflo

70 tablished risk factors, that is, obesity and tobacco smoking, are overrepresented among patients who

71 in Nha Trang, Vietnam, to evaluate paternal tobacco smoking as a risk factor for infectious and non-

72 bladder cancers are chemically induced, with tobacco smoking being the leading risk factor.

73 are hypothesized to contribute to relapse to tobacco smoking but mechanisms underlying and linking su

74 5 million deaths a year are attributable to tobacco smoking, but attempts to help people either quit

75 Modeled age-standardized prevalence of daily tobacco smoking by age, sex, country, and year; cigarett

76 nicotine consumption and prevent relapse to tobacco smoking by modulating glutamate transmission.

77 Tobacco smoking can account for some of the excess morta

78 Epidemiological studies indicate that tobacco smoking can be protective against neurodegenerat

79 Although residual confounding by tobacco smoking cannot be ruled out, this finding may re

80 important aim in public health worldwide as tobacco smoking causes many preventable deaths.

81 F reviewed the evidence on interventions for tobacco smoking cessation that are relevant to primary c

82 hanism contributing to its ability to aid in tobacco smoking cessation.

83 thylation in 5243 cancers of types for which tobacco smoking confers an elevated risk.

84 DNA adducts associated with tobacco smoking could provide a marker of biologically e

85 ibutable and unattributable to hypertension, tobacco smoking, diabetes mellitus, and obesity using an

86 Data on lifetime tobacco smoking, diet, education, and anthropometric mea

87 Tobacco smoking, driven by the addictive properties of n

88 has been reported that pre-conditioning with tobacco smoking during adolescence predisposes those you

89 Tobacco smoking during this age can compromise the norma

90 ChRs) may underlie differential nicotine and tobacco smoking effects and related behaviors in women v

91 Tobacco smoking enhances peri-implant soft tissue inflam

92 nd chemotherapy-responsive tumor, related to tobacco smoking, environmental arsenic exposure, industr

93 t risk reduction, followed by a reduction in tobacco smoking for men and obesity for women, but these

94 ine is clearly recognized by the tenacity of tobacco smoking for most users, and has prompted extensi

95 variety of psychiatric disorders, including tobacco smoking, for which there is strong evidence supp

96 % confidence interval [CI], 1.7-49.3), heavy tobacco smoking (>20 pack-years vs none; OR, 9.2; 95% CI

97 ught to be the key substance responsible for tobacco-smoking habits and appears to trigger reinforcem

98 Tobacco smoking has been associated with impaired pulmon

99 Tobacco smoking has been demonstrated to increase the ri

100 Tobacco smoking has been linked to an increased risk of

101 Tobacco smoking has many adverse health consequences.

102 Exposure to direct and passive tobacco smoking has significant impact on the gingival a

103 (reflux), higher body mass index (BMI), and tobacco smoking have been individually associated with e

104 factors related to DALYs were dietary risks, tobacco smoking, high body mass index, high blood pressu

105 Cumulative tobacco smoking histories and spirometry were obtained a

106 A 62-year-old man with a 45 pack per year tobacco-smoking history presented with painless gross he

107 ars (wave 10), mental health problems, daily tobacco smoking, illicit drug use, and dependence were a

108 ioural risk factors were unhealthy diets and tobacco smoking in 2015.

109 ne, a noradrenergic alpha2a agonist, reduced tobacco smoking in a 4-week trial and in animal models h

110 elated neuroadaptations of cAMP signaling to tobacco smoking in human subjects and suggest that smoki

111 The pooled prevalence of current tobacco smoking in pregnant women ranged from 0.6% (0.3-

112 interactions between FLG null mutations and tobacco smoking in relation to asthma.

113 modeled age-standardized prevalence of daily tobacco smoking in the population older than 15 years de

114 lysis of covariance with age (in months) and tobacco smoking (in pack-years) as covariates showed tha

115 from solid fuels (HAP; 7.0% [5.6-8.3]), and tobacco smoking including second-hand smoke (6.1% [5.4-6

116 ertainty interval 6.2-7.7] of global DALYs), tobacco smoking including second-hand smoke (6.3% [5.5-7

117 Despite declines, tobacco smoking including second-hand smoke remained the

118 Tobacco smoking increases the risk of at least 17 classe

119 Paternal tobacco smoking independently increased the risk of LRTI

120 ]PHNO PET may be more sensitive to measuring tobacco smoking-induced DA release in human tobacco smok

121 latory effects of nicotine in the brain (ie, tobacco smoking-induced upregulation of beta(2)*-nAChRs)

122 ttributable risk (PAR) of bladder cancer for tobacco smoking is 50% to 65% in men and 20% to 30% in w

123 Tobacco smoking is a chronic, relapsing disorder that co

124 Tobacco smoking is a major risk factor for many diseases

125 Tobacco smoking is a risk factor for numerous disorders,

126 Tobacco smoking is a well-known risk factor for subseque

127 Tobacco smoking is a worldwide public health problem.

128 Tobacco smoking is associated with a substantially eleva

129 Tobacco smoking is associated with chronic obstructive p

130 Tobacco smoking is associated with differential methylat

131 Parental tobacco smoking is associated with lower airway function

132 Tobacco smoking is considered a major modifiable risk fa

133 Once dependence on tobacco smoking is established, evidence suggests that t

134 Tobacco smoking is frequently abused by schizophrenia pa

135 Waterpipe tobacco smoking is growing in popularity despite adverse

136 ented in countries where ETS due to maternal tobacco smoking is negligible.

137 Tobacco smoking is the dominant risk factor for chronic

138 Tobacco smoking is the leading cause of preventable deat

139 Tobacco smoking is the leading risk factor for bladder c

140 Tobacco smoking is the major cause of lung cancer, and p

141 Tobacco smoking is the most important and well-establish

142 Worldwide, tobacco smoking is the principal lifestyle exposure that

143 Our results suggest that tobacco smoking may alter the genetic susceptibility to

144 Tobacco smoking may play an important role in both the o

145 ing that there are various pathways by which tobacco smoking might contribute to development of Barre

146 Tobacco smoking, nicotine in particular, is one of the r

147 At blood levels comparable with tobacco smoking, nicotine infusion does not appear to al

148 lcohol withdrawal with or without concurrent tobacco smoking/nicotine consumption resulted in signifi

149 Besides tobacco smoking, occupation, and other factors, diet may

150 Understanding the effects of tobacco smoking on neuroadaptations in GABAA receptor le

151 risk, we sought to investigate the impact of tobacco smoking on the risk of premature death and its c

152 ere we report on the sex-specific effects of tobacco smoking on transcriptomic and epigenetic feature

153 cancers, which could indicate confounding by tobacco smoking or reverse causality.

154 In contrast, tobacco smoking (OR = 0.96, 95% CI: 0.36-2.55), alcohol

155 This blunting may contribute to relapse to tobacco smoking, particularly in depression-vulnerable i

156 moking status, demographics, alcohol intake, tobacco smoking, physical activity, and included a food-

157 ome variable (the percentage point change in tobacco smoking prevalence between 2005 and 2015).

158 ver, this excess risk may be attributable to tobacco smoking rather than the three-fold higher preval

159 that acrolein is a major etiologic agent for tobacco smoking-related lung cancer.

160 We sought to quantify the burden of tobacco-smoking-related deaths in Asia, in parts of whic

161 Tobacco smoking remains an important public health issue

162 0.9-4.0) for 29 to 39 years and >39 years of tobacco smoking, respectively, as compared with those th

163 Addiction to tobacco smoking results from the binding of nicotine to

164 significantly increase risk for SP included tobacco smoking (RR, 2.47; 95% CI, 2.12-2.87), alcohol i

165 her odds of lung cancer after adjustment for tobacco smoking, serum cotinine levels, educational atta

166 , and overall relative prevalence ratios for tobacco smoking, smokeless tobacco use, and any tobacco

167 To assess how tobacco smoking status affects baseline dopamine D2/D3 (

168 gender, age at time of initial examination, tobacco smoking status at time of initial examination, p

169 e likely to smoke, and, after adjustment for tobacco-smoking status and other potential confounders,

170 y factors, including childhood maltreatment, tobacco smoking, substance dependence, psychiatric medic

171 a substantial decrease in the prevalence of tobacco smoking, the adverse health effects of tobacco s

172 s of four factors: HPV status, pack-years of tobacco smoking, tumor stage, and nodal stage.

173 Chronic exposure to nicotine, as in tobacco smoking, up-regulates nicotinic acetylcholine re

174 and cause-specific mortality associated with tobacco smoking using adjusted hazard ratios and their 9

175 between ages 40-60 after adjusting for age, tobacco smoking, viral load, and traditional risk factor

176 studies established for the first time that tobacco smoking was a risk factor for the development of

177 r, prevalence of psychiatric comorbidity and tobacco smoking was alarmingly high in severe patients w

178 healthy infants whether exposure to parental tobacco smoking was associated with airway hyperreactivi

179 Parental tobacco smoking was associated with lower baseline airwa

180 Tobacco smoking was associated with treatment escalation

181 The strongest association with tobacco smoking was found for lung cancer: a 3- to 4-fol

182 Current tobacco smoking was significantly associated with an inc

183 Thus, tobacco smoking was the main explanation for poor progno

184 eristics, especially alcohol consumption and tobacco smoking, we examined promoter methylation of the

185 Survey data that did not report daily tobacco smoking were adjusted using the average relation

186 Infants exposed to tobacco smoking were approximately half as likely to dev

187 Median pack-years of tobacco smoking were lower among p16-positive than p16-n

188 gh concentrations of nicotine resulting from tobacco smoking will cause an abnormal activation, a des

189 ng with gastresophageal reflux, obesity, and tobacco smoking with genome-wide significance.